<DOC>
	<DOCNO>NCT01178164</DOCNO>
	<brief_summary>Fabry disease ( FD ) rare X-linked multisytemic lysosomal disorder cause alpha-galactosidase deficiency . Globotriaosylc√©ramide ( Gb3 ) deposit observe almost tissue examine . Signs disease appear earlier severe affected male female . Myocardiopathy , renal failure neurological sign include chronic pain peripheral neuropathy frequent sign . The availability two enzymatic replacement therapy provide specific effective treatment patient . The prevalence FD estimate 1/40,000 1/117,000 . The frequency Fabry disease previously estimate several series patient present one single sign , ie renal failure , hypertrophic myocardiopathy early onset stroke . However , data available prevalence FD population patient suffer chronic pain unknown origin . The diagnosis FD perform standard procedure follow international recommendation . These require search deficiency alphagalactosidase A activity leucocytes male genetic analysis GLA gene female ( Lidove et al . 2007 ) . The patient diagnosis FD establish study , call additional visit Investigating Centre order confirm diagnosis propose suitable assessment care .</brief_summary>
	<brief_title>Prevalence Fabry 's Disease Population Patients With Chronic Pains</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Fabry Disease</mesh_term>
	<criteria>patient sex age 6 65 chronic pain unknown aetiology include : acroparesthesias and/or pain crisis evolve 3 month continue neuropathic evolve 3 month and/or multiple pain evolve 3 month and/or recurrent abdominal crisis pain come clinical visit Centre Douleurs Chroniques CHU Bordeaux . chronic pain know cause</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>chronic pain</keyword>
	<keyword>unknown aetiology</keyword>
</DOC>